Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Adaptive Biotechnologies Corp (ADPT) USD0.0001

Sell:$28.22 Buy:$28.26 Change: $0.34 (1.22%)
NASDAQ:0.04%
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$28.22
Buy:$28.26
Change: $0.34 (1.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
Sell:$28.22
Buy:$28.26
Change: $0.34 (1.22%)
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Adaptive Biotechnologies Corp is a biotechnology company. The Company is focused on using the biology of the adaptive immune system to develop the diagnosis and treatment of disease. Its immune medicine platform generates clinical immunomics data to decode the adaptive immune system. Its products and pipeline includes immunoSEQ, clonoSEQ and cellular therapy. It offers its immunoSEQ technology as a service and a kit. immunoSEQ utilizes bias-controlled polymerase chain reaction (PCR) to sequence immune receptors from deoxyribonucleic (DNA). clonoSEQ is its diagnostic test product for the detection and next-generation sequencing (NGS)-based monitoring of minimal residual disease (MRD) in bone marrow samples in patients with myeloma (MM) and acute lymphoblastic leukemia (ALL). clonoSEQ is designed to sequence all rearranged receptor sequences in a tumor in parallel to enable MRD monitoring. It also focuses on developing immune-mediated therapies in oncology and other disease areas.

Contact details

Address:
1551 Eastlake Ave E Ste 200
SEATTLE
98102-7402
United States
Telephone:
+1 (206) 6590067
Website:
https://www.adaptivebiotech.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
ADPT
ISIN:
US00650F1093
Market cap:
$3.57 billion
Shares in issue:
124.32 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Chad Robins
    President, Chief Executive Officer, Co-Founder
  • Harlan Robins
    Co-Founder, Chief Scientific Officer
  • Dean Schorno
    Chief Financial Officer
  • Nancy Hill
    Senior Vice President, General Manager - Research Products
  • .. Willis
    Senior Vice President, General Manager - Diagnostic Products

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.